C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

(2021) Shohei Fukuda et al.   Journal for ImmunoTherapy of Cancer

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

(2021) Laura Mezquita et al.   EUROPEAN JOURNAL OF CANCER

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

(2020) Jakob M. Riedl et al.   Cancers

Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer

(2020) Jeong Uk Lim et al.   CYTOKINE

Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer

(2019) Yuichi Ozawa et al.   MEDICAL ONCOLOGY

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

(2019) Yucai Wang et al.   JAMA Oncology

Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer

(2019) Fiamma Berner et al.   JAMA Oncology

Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

(2018) Aly-Khan A. Lalani et al.   Journal for ImmunoTherapy of Cancer

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

(2017) Lesley Seymour et al.   LANCET ONCOLOGY

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

(2016) J.M. Michot et al.   EUROPEAN JOURNAL OF CANCER

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

(2016) Geoffrey T Gibney et al.   LANCET ONCOLOGY

Pseudoprogression and Immune-Related Response in Solid Tumors

(2015) Victoria L. Chiou et al.   JOURNAL OF CLINICAL ONCOLOGY

C-reactive protein as a biomarker for urological cancers

(2011) Kazutaka Saito et al.   Nature Reviews Urology